3 COVID-19 Stocks That Should Beat the Market in 2022

[view original post]

[unable to retrieve full-text content]Given the ongoing need for active development of its vaccines, it’s a no-brainer that Moderna is going to crush the market next year just like it did this year. Demand for Spikevax is still growing, …